Cite
HARVARD Citation
Reid, M. et al. (n.d.). A double‐blind, placebo‐controlled phase II study of the efficacy and safety of 2, 2‐dimethylbutyrate (HQK‐1001), an oral fetal globin inducer, in sickle cell disease. American journal of hematology. 89 (7), pp. 709-713. [Online].